|
Author(s), year | Sample size | Mean age (year) | Interventions | Duration (month) |
Control | Experimental | Control | Experimental |
|
Liu 2016 [11] | 100 | 69±2.01 | 68±2.39 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g, TID) | 6 |
Gao 2017 [12] | 68 | 56.7±8.2 | 56.7±8.2 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Liu 2016 [13] | 110 | 62.32±5.36 | 62.32±5.36 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Liu 2012 [14] | 50 | 59.2±16.8 | 59.2±16.8 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Meng 2016 [15] | 116 | 56±8.5 | 55±9.5 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Wang 2015 [16] | 86 | 57.3±2.5 | 57.3±2.5 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Zhang 2015 [17] | 112 | 63.3±4.2 | 63.7±5.8 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Liu 2013 [18] | 135 | 55.1±8.2 | 55.9±8.4 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Mei 2013 [19] | 134 | 56.3±5.8 | 58.7±7.1 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Yang 2016 [20] | 80 | 56±15.6 | 54.2±14.6 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
Zhu 2013 [21] | 150 | 62.39±5.69 | 62.39±5.69 | Atorvastatin 20mg/d Aspirin 100mg/d | Atorvastatin 20mg/d Aspirin 100mg/d Naoxintong (1.6g,TID) | 6 |
|